Naked Caspase-3 Sirna Amplifies Inflammation Via TLR and PKR Signaling in a Porcine Renal Auto-transplantation Model
Cheng Yang,Long Li,Yinjia Xue,Zitong Zhao,Tian Zhao,Yichen Jia,Ruiming Rong,Ming Xu,Michael L. Nicholson,Tongyu Zhu,Bin Yang
DOI: https://doi.org/10.3389/conf.fimmu.2013.02.00276
IF: 7.3
2013-01-01
Frontiers in Immunology
Abstract:Event Abstract Back to Event Naked Caspase-3 siRNA Amplifies Inflammation via TLR and PKR Signaling in a Porcine Renal Auto-transplantation Model Cheng Yang1, 2, Long Li1, 2, Yinjia Xue1, 2, Zitong Zhao1, 2, Tian Zhao1, 2, Yichen Jia1, 2, Ruiming Rong1, 2, Ming Xu1, 2, Michael L. Nicholson3, Tongyu Zhu1, 2* and Bin Yang3, 4* 1 Zhongshan Hospital, Fudan University, China 2 Shanghai Key Laboratory of Organ Transplantation, China 3 Leicester General Hospital, University Hospitals of Leicester, Transplant Group, Department of Infection, Immunity and Inflammation, University of Leicester, United Kingdom 4 Affiliated Hospital of Nantong University, University of Nantong, Department of Nephrology, China Background. Small interfering RNA (siRNA) has the potential to elicit innate immune responses and trigger interferon responses like long, double-stranded RNA. In our previous study, naked caspase-3 siRNA infused into the renal artery during cold preservation was effective, but did not protect the auto-transplant kidneys in a porcine model, with increased inflammation and apoptosis. Therefore, there is a warranty to further elucidate whether the siRNA activates innate immune responses and which signaling pathways are involved. Materials and Methods. The left kidney was retrieved from mini pigs and infused by University of Wisconsin solution with/without 0.3 mg caspase-3 siRNA into the renal artery with the renal artery and vein clamped for 24-h cold storage. After right nephrectomy, the left kidney was auto-transplanted into the right for 48-h without siRNA systemic treatment. The protein expression was detected by western blotting, while the mRNA expression was detection by qPCR. Results. The protein level of toll like receptor (TLR)-3 and TLR-7, as well as their main adapters, TRIF and MyD88, was up-regulated by the siRNA in the auto-transplant kidneys. Furthermore, the mRNA level of inflammatory transcription factors, NF-κB and c-Jun, was also increased, which resulted in the enhanced mRNA expression of pro-inflammatory cytokines, including IL-1β and IL-6, TNF-α and interferon (IFN)-α, β and γ. The protein of PKR, an non-TLR RNA sensor, was also up-regulated by the siRNA, but RIG-1 was not affected. Conclusion. Naked caspase-3 siRNA administered into the kidney activated TLR- and PKR-mediated innate immune responses, and then amplified inflammation, which provided valuable evidence to guide future pre-clinic studies. Figure 1 Acknowledgements This study was supported by the UK-China Fellowship for Excellence, Department for Business Innovation and Skills; University Hospitals of Leicester NHS Trust, UK, and National Natural Science Foundation of China (81170689, 81270832, 81270833); Science and Technology Commission of Shanghai Municipality (12ZR1405500); Zhongshan Hospital, Fudan University, China. References 1.Yang B, Hosgood SA, Nicholson ML. Naked small interfering RNA of caspase-3 in preservation solution and autologous blood perfusate protects isolated ischemic porcine kidneys. Transplantation 2011; 91 (5): 501. 2.Yang C, Jia Y, Zhao T, et al. Naked caspase 3 small interfering RNA is effective in cold preservation but not in autotransplantation of porcine kidneys. J Surg Res 2012. 3.Robbins M, Judge A, MacLachlan I. siRNA and innate immunity. Oligonucleotides 2009; 19 (2): 89. 4.Zheng X, Zhang X, Sun H, et al. Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation 2006; 82 (12): 1781. 5.Zheng X, Feng B, Chen G, et al. Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am J Transplant 2006; 6 (9): 2099. 6.Zhang YX, Fan H, Shi Y, et al. Prevention of lung ischemia-reperfusion injury by short hairpin RNA-mediated caspase-3 gene silencing. J Thorac Cardiovasc Surg 2010; 139 (3): 758. 7.Ishikawa S, Hirata A, Nakabayashi J, Iwakiri R, Okinami S. Neuroprotective effect of small interfering RNA targeted to caspase-3 on rat retinal ganglion cell loss induced by ischemia and reperfusion injury. Curr Eye Res 2012; 37 (10): 907. 8.Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303 (5663): 1526. 9.Hornung V, Guenthner-Biller M, Bourquin C, et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005; 11 (3): 263. 10.Gantier MP, Tong S, Behlke MA, et al. TLR7 is involved in sequence-specific sensing of single-stranded RNAs in human macrophages. J Immunol 2008; 180 (4): 2117. 11.Forsbach A, Nemorin JG, Montino C, et al. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J Immunol 2008; 180 (6): 3729. 12.Kariko K, Bhuyan P, Capodici J, Weissman D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol 2004; 172 (11): 6545. 13.Kleinman ME, Yamada K, Takeda A, et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 2008; 452 (7187): 591. 14.Weber C, Muller C, Podszuweit A, Montino C, Vollmer J, Forsbach A. Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects). Immunology 2012; 136 (1): 64. 15.Heidel JD, Hu S, Liu XF, Triche TJ, Davis ME. Lack of interferon response in animals to naked siRNAs. Nat Biotechnol 2004; 22 (12): 1579. 16.Judge AD, Sood V, Shaw JR, Fang D, McClintock K, MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 2005; 23 (4): 457. 17.Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol 2005; 348 (5): 1079. 18.Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002; 168 (2): 554. 19.Chen J, John R, Richardson JA, et al. Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int 2011; 79 (3): 288. 20.Arpaia N, Barton GM. Toll-like receptors: key players in antiviral immunity. Curr Opin Virol 2011; 1 (6): 447. 21.Chang WJ, Toledo-Pereyra LH. Toll-like receptor signaling in liver ischemia and reperfusion. J Invest Surg 2012; 25 (4): 271. 22.Leventhal JS, Schroppel B. Toll-like receptors in transplantation: sensing and reacting to injury. Kidney Int 2012; 81 (9): 826. 23.Ding HS, Yang J, Gong FL, Ding JW, Li S, Jiang YR. High mobility group [corrected] box 1 mediates neutrophil recruitment in myocardial ischemia-reperfusion injury through toll like receptor 4-related pathway. Gene 2012; 509 (1): 149. 24.Lei C, Lin S, Zhang C, et al. High-mobility group box1 protein promotes neuroinflammation after intracerebral hemorrhage in rats. Neuroscience 2013; 228: 190. 25.Rabadi MM, Ghaly T, Goligorksy MS, Ratliff BB. HMGB1 in renal ischemic injury. Am J Physiol Renal Physiol 2012; 303 (6): F873. 26.Yang H, Hirooka K, Liu Y, et al. Deleterious role of anti-high mobility group box 1 monoclonal antibody in retinal ischemia-reperfusion injury. Curr Eye Res 2011; 36 (11): 1037. 27.Okuma Y, Liu K, Wake H, et al. Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Ann Neurol 2012; 72 (3): 373. 28.Munir M, Berg M. The multiple faces of proteinkinase R in antiviral defense. Virulence 2013; 4 (1): 85. 29.Han Q, Zhang C, Zhang J, Tian Z. Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition. PLoS One 2011; 6 (12): e27931. 30.Clark KL, Hughes SA, Bulsara P, et al. Pharmacological Characterization of a Novel ENaCalpha siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis. Mol Ther Nucleic Acids 2013; 2: e65. 31.Ghanty U, Fostvedt E, Valenzuela R, Beal PA, Burrows CJ. Promiscuous 8-alkoxyadenosines in the guide strand of an siRNA: modulation of silencing efficacy and off-pathway protein binding. J Am Chem Soc 2012; 134 (42): 17643. 32.Yang B, Elias JE, Bloxham M, Nicholson ML. Synthetic small interfering RNA down-regulates caspase-3 and affects apoptosis, IL-1 beta, and viability of porcine proximal tubular cells. J Cell Biochem 2011; 112 (5): 1337. Keywords: small interfering RNA, innate immunity, Toll like receptor, PKR, Porcine Kidney Auto-transplantation, Ischemia Reperfusion Injury. Conference: 15th International Congress of Immunology (ICI), Milan, Italy, 22 Aug - 27 Aug, 2013. Presentation Type: Abstract Topic: Innate immunity Citation: Yang C, Li L, Xue Y, Zhao Z, Zhao T, Jia Y, Rong R, Xu M, Nicholson ML, Zhu T and Yang B (2013). Naked Caspase-3 siRNA Amplifies Inflammation via TLR and PKR Signaling in a Porcine Renal Auto-transplantation Model. Front. Immunol. Conference Abstract: 15th International Congress of Immunology (ICI). doi: 10.3389/conf.fimmu.2013.02.00276 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 12 Mar 2013; Published Online: 22 Aug 2013. * Correspondence: Prof. Tongyu Zhu, Zhongshan Hospital, Fudan University, Shanghai, China, tyzhu_dr@163.com Prof. Bin Yang, Leicester General Hospital, University Hospitals of Leicester, Transplant Group, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom, by5@le.ac.uk Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Cheng Yang Long Li Yinjia Xue Zitong Zhao Tian Zhao Yichen Jia Ruiming Rong Ming Xu Michael L Nicholson Tongyu Zhu Bin Yang Google Cheng Yang Long Li Yinjia Xue Zitong Zhao Tian Zhao Yichen Jia Ruiming Rong Ming Xu Michael L Nicholson Tongyu Zhu Bin Yang Google Scholar Cheng Yang Long Li Yinjia Xue Zitong Zhao Tian Zhao Yichen Jia Ruiming Rong Ming Xu Michael L Nicholson Tongyu Zhu Bin Yang PubMed Cheng Yang Long Li Yinjia Xue Zitong Zhao Tian Zhao Yichen Jia Ruiming Rong Ming Xu Michael L Nicholson Tongyu Zhu Bin Yang Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.